Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Dimitrova · SciRah

Researcher profile · Semantic Scholar

E. Dimitrova

Share profile

E. Dimitrova — researcher profile on SciRah

h-index: 5
Works: 29
Citations: 161

Most-cited papers

Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
M. Petrova, M. Eneva, J. Arabadjiev, N. Conev +10 more
2020BioScience Trends54 citations Open access
Semantic Scholar
RIPK3 expression as a potential predictive and prognostic marker in metastatic colon cancer.
N. Conev, E. Dimitrova, M. Bogdanova, Yavor Kashlov +10 more
2019Clinical and investigative medicine. Medecine clinique et experimentale38 citations Open access
Semantic Scholar
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer
M. Petrova, I. Donev, M. Radanova, M. Eneva +14 more
2020Clinical and Experimental Immunology36 citations Open access
Semantic Scholar
Association Between Serum CK-18 Levels and the Degree of Liver Damage in Fructose-Induced Metabolic Syndrome
K. Bratoeva, S. Nikolova, A. Merdzhanova, G. Stoyanov +4 more
2018Metabolic Syndrome and Related Disorders11 citations
Semantic Scholar
KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
M. Radanova, G. Mihaylova, George St. Stoyanov, Vyara Draganova +5 more
2023International Journal of Molecular Sciences6 citations Open access
Semantic Scholar
Prevalence and prognosis of PIK3CA mutations in Bulgarian patients with metastatic breast cancer receiving endocrine therapy in first‐line setting
R. Gencheva, M. Petrova, P. Kraleva, S. Hadjidekova +16 more
2023Cancer Reports3 citations Open access
Semantic Scholar
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
Георги Тодоров, Чавдар Бъчваров, Георги Вълчев, Николай Колев +16 more
20183 citations
Semantic Scholar
A pictorial view on false positive findings of 68Ga-PSMA-11 PET/CT and their prognostic value in patients with prostate carcinoma after radical prostatectomy and undetectable PSA values.
Z. Dancheva, S. Chausheva, T. Stoeva, M. Dyankova +9 more
2024Hellenic journal of nuclear medicine2 citations
Semantic Scholar
Sarcopenia as a negative predictive marker for treatment with pembrolizumab as a second line in patients with metastatic non-small cell lung cancer.
M. Petrova, G. Valchev, N. Conev, E. Dimitrova +11 more
20201 citations
Semantic Scholar
1698P The presence of COVID-19 makes more cancer patients distressed and time perception may distinguish them
N. V. Conev, M. Petrova, E. Dimitrova, K. Zhelev +6 more
2020Annals of Oncology1 citations Open access
Semantic Scholar
Time perception as a novel ultra-short screening tool for distress in cancer patients.
N. Conev, I. Donev, D. Stoyanov, M. Ivanova +2 more
20181 citations
Semantic Scholar
Role of the pretreatment 18F-fluorodeoxyglucose positron emission tomography maximal standardized uptake value in predicting outcomes of colon liver metastases and that value's association with Beclin-1 expression.
E. Dimitrova, B. Chaushev, N. Conev, Javor K. Kashlov +7 more
2017BioScience Trends1 citations Open access
Semantic Scholar
Embolization of bronchial arteries in cases of life-threatening bleeding
G. Todorov, Chavdar Bachvarov, G. Valchev, R. Popova +4 more
20151 citations Open access
Semantic Scholar
Policy Proposal to the Solicitors Regulation Authority Transitional Fairness and Recognition of Prior Learning under the Solicitors Qualifying Examination (SQE) Framework
E. Dimitrova
2025Social Science Research Network0 citations Open access
Semantic Scholar
PI3KCA mutation prevalence and outcome among patients with metastatic breast cancer in Bulgaria treated with first-line endocrine therapy.
R. Gencheva, S. Hadjidekova, M. Petrova, D. Krŭstev +14 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Patient resilience and distress level prior to chemotherapy based on time estimation.
P. Kraleva, M. Petrova, Teodor Popov, N. Conev +9 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
P-216 Serum levels of HMGB1 might have a predictive role for neoadjuvant radiotherapy combined with chemotherapy in rectal cancer patients
T. Radeva-Petkova, E. Encheva, G. Mihaylova, D. Palamudova +5 more
2022Annals of Oncology0 citations Open access
Semantic Scholar
Key Apoptosis Signaling Pathways In Malignant Diseases
T. Panayotova, D. Stoyanov, R. Manev, Margarita Maneva +3 more
2021Varna Medical Forum0 citations Open access
Semantic Scholar
High neutrophil to lymphocyte ratio as a predictor for hyperprogressive disease in patients with metastatic non-small cell lung cancer treated with pembrolizumab as a second line.
M. Petrova, M. Eneva, J. Arabadjiev, N. Conev +11 more
2020Journal of Clinical Oncology0 citations
Semantic Scholar
Gender and time estimation as novel potent indicators of emotional concerns in cancer patients.
A. Yanchev, M. Ivanova, I. Donev, E. Dimitrova +1 more
20200 citations
Semantic Scholar
Dynamic of time estimation and its relation with levels of distress.
N. Conev, M. Ivanova, E. Dimitrova, A. Yanchev +1 more
20200 citations
Semantic Scholar
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies
G. Todorov, Chavdar Bachvarov, G. Valchev, N. Kolev +6 more
20180 citations
Semantic Scholar
Expression of hepatic HMGB1 levels in fructose-induced fatty liver
K. Bratoeva, E. Dimitrova, N. Conev, Javor K. Kashlov +4 more
2018Varna Medical Forum0 citations Open access
Semantic Scholar
Neurotoxicity of cancer agents
N. Conev, I. Shterev, R. Manev, E. Dimitrova +6 more
20180 citations
Semantic Scholar
Regulation of cell death in cancer diseases - importance and therapeutic effect
K. Bratoeva, E. Dimitrova, N. Conev, G. Todorov +3 more
20170 citations
Semantic Scholar
FIRST LINE 5-FU-BASED CHEMOTHERAPY WITH/ WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: TISSUE BIOMARKER CANDIDATES
A. Konsoulova, I. Donev, N. Conev, S. Draganova +5 more
20160 citations Open access
Semantic Scholar
FIRST LINE 5!FU!BASED CHEMOTHERAPY WITH/ WITHOUT BEVACIZUMAB FOR METASTATIC COLORECTAL CANCER: ONE CENTER EXPERIENCE RESULTS
A. Konsoulova, I. Donev, N. Conev, S. Draganova +6 more
20150 citations
Semantic Scholar
2-year single center clinical experience in patients with colon cancer stage II and III receiving adjuvant chemotherapy
N. Conev, I. Donev, E. Dimitrova, M. Kozhuharova +3 more
20150 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

N. Conev×22
Invite
N. Conev — researcher profile on SciRah
I. Donev×18
Invite
I. Donev — researcher profile on SciRah
G. Zhbantov×6
Invite
G. Zhbantov — researcher profile on SciRah
K. Bratoeva×6
Invite
K. Bratoeva — researcher profile on SciRah

×5

Invite

M. Eneva — researcher profile on SciRah

Invite

R. Gencheva — researcher profile on SciRah

Chavdar Bachvarov×5

Invite

Chavdar Bachvarov — researcher profile on SciRah

Invite

G. Todorov — researcher profile on SciRah

J. Arabadjiev×4

Invite

J. Arabadjiev — researcher profile on SciRah

T. Karanikolova×4

Invite

T. Karanikolova — researcher profile on SciRah

Invite

A. Ivanova — researcher profile on SciRah

Invite

M. Radanova — researcher profile on SciRah